Literature DB >> 15636655

Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.

Jeanette R M White1, Michael A Veltri, James C Fackler.   

Abstract

OBJECTIVE: To prospectively identify and reduce proximal causes of error contributing to inappropriate intravenous potassium chloride orders and reduce adverse events subsequent to these ordering errors.
DESIGN: Pre-post cohort study of the reduction in both proximal causes of error and number of postinfusion elevated serum potassium levels after intervention.
SETTING: Sixteen-bed, tertiary care, urban, academic pediatric intensive care unit. PATIENTS: Children 0-18 yrs old receiving intravenous potassium chloride in the pediatric intensive care unit.
INTERVENTIONS: A multidisciplinary team determined proximal causes of error that were likely contributors to the occurrence of the outcome measure, elevated potassium levels after intravenous potassium chloride. A mandatory drug request form was designed for physicians ordering intravenous potassium chloride. The drug request form was designed to reduce proximal causes of error and, as a result, elevated potassium levels after intravenous potassium chloride. Demographic and laboratory data on children receiving intravenous potassium chloride in the pediatric intensive care unit and details of the drug order were analyzed.
MEASUREMENTS AND MAIN RESULTS: Data from 1,492 intravenous potassium chloride administration-events before implementation of the drug request form were collected. After the drug request form was mandated, 166 consecutively completed forms were collected and analyzed. The incidence of postinfusion elevations in serum potassium decreased from a rate of 7.7% (103 of 1,341) before the drug request form to 0% (0 of 150) after the drug request form (p < .001). Proximal causes of error were also reduced. The number of patients with a creatinine >/=2 mg/dL receiving intravenous potassium chloride decreased from 28.4% to 14.2% (p < .001). The number of intravenous potassium chloride infusions administered to patients where serum potassium value was >4.5 mmol/L decreased significantly (2.9% vs. 0.0%, p < .02). The incidence rates of both verbal orders and failure to write the order in a correct format were reduced to zero.
CONCLUSIONS: Simple, blame-free, system-wide interventions designed to reduce proximal causes of error can be an effective, proactive means of reducing the likelihood of medical morbidity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15636655     DOI: 10.1097/01.PCC.0000149832.76329.90

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  7 in total

Review 1.  Incidents and errors in neonatal intensive care: a review of the literature.

Authors:  C Snijders; R A van Lingen; A Molendijk; W P F Fetter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-03-21       Impact factor: 5.747

Review 2.  Interventions to reduce dosing errors in children: a systematic review of the literature.

Authors:  Sharon Conroy; Dimah Sweis; Claire Planner; Vincent Yeung; Jacqueline Collier; Linda Haines; Ian C K Wong
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients.

Authors:  Jarrod D Knudson; Adam W Lowry; Jack F Price; Brady S Moffett
Journal:  Pediatr Cardiol       Date:  2012-11-04       Impact factor: 1.655

Review 4.  Interventions to reduce medication errors in neonatal care: a systematic review.

Authors:  Minh-Nha Rhylie Nguyen; Cassandra Mosel; Luke E Grzeskowiak
Journal:  Ther Adv Drug Saf       Date:  2017-12-28

5.  Improving the safety of high-concentration potassium chloride injection.

Authors:  Kaoru Nakatani; Etsuko Nakagami-Yamaguchi; Yoshikatsu Shinoda; Shuhei Tomita; Tatsuya Nakatani
Journal:  BMJ Open Qual       Date:  2019-06-12

Review 6.  What causes prescribing errors in children? Scoping review.

Authors:  Richard L Conn; Orla Kearney; Mary P Tully; Michael D Shields; Tim Dornan
Journal:  BMJ Open       Date:  2019-08-10       Impact factor: 2.692

7.  Systemic Defenses to Prevent Intravenous Medication Errors in Hospitals: A Systematic Review.

Authors:  Sini Karoliina Kuitunen; Ilona Niittynen; Marja Airaksinen; Anna-Riia Holmström
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.